THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY-Reference-Cited by-同舟云学术

THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY

Published:2007-04-01 Issue:4 Volume:60 Page:601-612
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Neuwelt Edward A.¹,Várallyay Csanád G.²,Manninger Sándor²,Solymosi Diána²,Haluska Marianne³,Hunt Matthew A.⁴,Nesbit Gary⁵,Stevens Alexander⁶,Jerosch-Herold Michael⁷,Jacobs Paula M.⁸,Hoffman John M.⁹

Affiliation:

1. Departments of Neurology and Neurosurgery, Oregon Health & Science University, and Veteran's Administration Medical Center, Portland, Oregon

2. Departments of Neurology and Radiology, Oregon Health & Science University, Portland, Oregon

3. Department of Radiology, Oregon Health & Science University, Portland, Oregon

4. Department of Neurosurgery, Oregon Health & Science University, Portland, Oregon

5. Departments of Neurology, Neurosurgery, and Radiology, Oregon Health & Science University, Portland, Oregon

6. Department of Psychiatry, Oregon Health & Science University, Portland, Oregon

7. Department of Radiology and Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon

8. SAIC-Frederick, Inc., Frederick, Maryland, and Cancer Imaging Program, National Cancer Institute, Bethesda, Maryland

9. Department of Radiology, University of Utah, Salt Lake City, Utah

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/60/4/601/24872652/neurosurgery-60-4-601.pdf

Reference40 articles.

1. Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial;Akella;J Magn Reson Imaging,2004

2. Time-dependency in brain lesion enhancement with gadodiamide injection;Akeson;Acta Radiol,1997

3. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck;Anzai;AJNR Am J Neuroradiol,1994

4. Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice;Bremer;Radiology,2003

5. Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected];Cao;Int J Radiat Oncol Biol Phys,2006

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Reproducible Is Feraheme® (Ferumoxytol Injection)? Comparison of Size, Zeta Potential, and Complement Activation of Different Batches over 15 Years;Journal of Nanotheranostics;2024-09-03

2. Ferumoxytol-Enhanced MRI in Brain Tumor Imaging;Advances in Clinical Radiology;2024-09

3. The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts;Abdominal Radiology;2024-04-01

4. Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI;National Science Review;2024-02-07

5. MRI Detection and Therapeutic Enhancement of Ferumoxytol Internalization in Glioblastoma Cells;Nanomaterials;2024-01-13